These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 23373823

  • 1. Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.
    Denis MA, Cosyns JP, Persu A, Dewit O, de Galocsy C, Hoang P, Maldague P, Wallemacq P, Zerbib F, Fiasse R.
    Eur J Clin Invest; 2013 Mar; 43(3):292-301. PubMed ID: 23373823
    [Abstract] [Full Text] [Related]

  • 2. [Secondary (AA) amyloidosis in Crohn's disease].
    Bulum T, Prkacin I, Cavrić G, Sobocan N, Skurla B, Duvnjak L, Bulimbasić S.
    Acta Med Croatica; 2011 Mar; 65(3):271-8. PubMed ID: 22359896
    [Abstract] [Full Text] [Related]

  • 3. [Renal amyloidosis complicating Crohn's disease: report of two cases and review of literature].
    Elloumi H, Ben Slama A, Arfaoui D, Ghouma M, Sfar S, Ajmi S.
    Tunis Med; 2006 Apr; 84(4):253-5. PubMed ID: 16832997
    [Abstract] [Full Text] [Related]

  • 4. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A, Zake T, Groma V, Ostrovskis E, Skuja S, Pokrotnieks J.
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
    Simsek I, Kaya A, Erdem H, Pay S, Yenicesu M, Dinc A.
    J Nephrol; 2010 Sep; 23(1):119-23. PubMed ID: 20091495
    [Abstract] [Full Text] [Related]

  • 7. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M, Immunopathology Group of the Italian Society of Nephrology.
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [Abstract] [Full Text] [Related]

  • 8. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H, Boubaker K, Béji S, Abderrahim E, Moussa FB, Turki S, Goucha R, Hedri H, El Younsi F, Kheder A, Maiz HB.
    Transplant Proc; 2004 Mar; 36(6):1796-8. PubMed ID: 15350480
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.
    Verine J, Mourad N, Desseaux K, Vanhille P, Noël LH, Beaufils H, Grateau G, Janin A, Droz D.
    Hum Pathol; 2007 Dec; 38(12):1798-809. PubMed ID: 17714761
    [Abstract] [Full Text] [Related]

  • 11. [Reversible nephrotic syndrome in Crohn's disease complicated with renal amyloidosis].
    Larvol L, Cervoni JP, Besnier M, Dupouet L, Beaufils H, Clauvel JP, Levecq H.
    Gastroenterol Clin Biol; 1998 Dec; 22(6-7):639-41. PubMed ID: 9762336
    [Abstract] [Full Text] [Related]

  • 12. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    Basturk T, Ozagari A, Ozturk T, Kusaslan R, Unsal A.
    J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
    [Abstract] [Full Text] [Related]

  • 13. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB, Madhoo S, Pepys MB, Hawkins PN.
    Gastroenterology; 1997 Apr; 112(4):1362-5. PubMed ID: 9098022
    [Abstract] [Full Text] [Related]

  • 14. [A case of systemic AA amyloidosis complicating Crohn's disease].
    Muro K, Kobayashi M, Shimizu Y, Kikuchi S, Yamaguchi N, Inadome Y, Watanabe T, Koyama A.
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):284-9. PubMed ID: 9654912
    [Abstract] [Full Text] [Related]

  • 15. Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid deposition.
    Pamuk ON, Donmez S, Pamuk GE, Puyan FO, Keystone EC.
    Amyloid; 2013 Dec; 20(4):245-50. PubMed ID: 24106838
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
    Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, Mariette X.
    Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Secondary amyloidosis (AA) and renal disease].
    Torregrosa E, Hernández-Jaras J, Calvo C, Ríus A, García-Pérez H, Maduell F, Vera JM.
    Nefrologia; 2003 Jul; 23(4):321-6. PubMed ID: 14558331
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AA amyloidosis: Mount Sinai experience, 1997-2012.
    Bunker D, Gorevic P.
    Mt Sinai J Med; 2012 Jul; 79(6):749-56. PubMed ID: 23239212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.